Skip to content
Home/Companies/Healthcare/Ten63 Therapeutics
TT

Ten63 Therapeutics

Healthcare·UK·Active

Ten63 Therapeutics is a healthcare company, headquartered in UK.

Entry
–
Hold
–
Status
Active
Est. EV
–

Who owns Ten63 Therapeutics?

Ten63 Therapeutics is currently owned by Ryse Asset Management through RYSE Special Opportunities Fund (2024 vintage).

Hand-verified · updated 2026-04-21

Ryse Asset Management
Investor
Ryse Asset Management
RYSE Special Opportunities Fund · 2024 · VC

Key facts

HQUK
SectorHealthcare

More from RYSE Special Opportunities Fund

Other portfolio companies in the same fund.

696ab0a38adbbeb2ab592963 Amazon
Active
TMTUS
696ab0bacf4c13535f10cb03 Best%20buy
Active
ConsumerUS
696ab0bae3122f35ed1821c3 Lowe%27s%20
Active
ConsumerUS
696ab0bae421b2100b5f98f1 Linen%20chest
Active
ConsumerUS
6994d1a098b07b9a438a146f Ryse
Active
FinancialsUS
69a1c31e532f2688207f0e06 Wired
Active
TMTUS

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
4ways
Active
ECI PartnersUK
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abcam (exited)
Active
EMV CapitalUK
Data refreshed weekly · Sourced from public filings